Purpose: It has been reported that 10% to 20% of children with Kawasaki disease (KD) will not respond to intravenous immunoglobulin (IVIG) treatment. In this study, we aimed to identify useful predictors of therapeutic failure in children with KD. Methods: We examined 309 children diagnosed with KD at the Kyungpook National University Hospital and the Inje University Busan Paik Hospital between January 2005 and June 2011. We retrospectively reviewed their medical records and analyzed multiple parameters in responders and nonresponders to IVIG. Results: Among the 309 children, 30 (9.7%) did not respond to IVIG. They had significantly higher proportion of neutrophils, and higher levels of aspartate aminotransferase, alanine aminotransferase (ALT), total bilirubin, and N-terminal fragment of B-type natriuretic peptide than did responders. IVIGnonresponders had a significantly longer duration of hospitalization, and more frequently experienced coronary artery lesion, and sterile pyuria. No differences in the duration of fever at initial treatment or, clinical features were noted. Conclusion: Two independent predictors (ALT≥84 IU/L, total bilirubin≥0.9 mg/dL) for nonresponse were confirmed through multivariate logistic regression analysis. Thus elevated ALT and total bilirubin levels might be useful in predicting nonresponse to IVIG therapy in children with KD.
Introduction
Kawasaki disease (KD) is systemic vasculitis that can cause coronary artery com plications, and is the most common cause of pediatric acquired cardiac disease in developed countries. Some cases are recovered naturally without treatment, but around 15% to 25% have complications such as coronary aneurysm and coronary artery ectasia. Such complications may develop into cardiac infarction, sudden death or ischemic heart disease 1, 2) . The use of highdose intravenous immunoglobulin (IVIG) and aspirin lowered the frequency of coronary artery complications caused by KD to below 5%, and its morbidity and mortality also went down 3) . Though its mechanism of action is not clear, immunoglobulin has a systemic antiinflammatory action, modulating the production of cytokine, neutralizing bacterial superantigen or other etiologic agents, amplifying Tcell suppressor activity, and inhibiting the production of antibody 2, 3) . However, 10% to 20% of KD patients do not respond to the conventional therapy and have continued fever, and such cases are in need of a different rescue therapy 4, 5) . In the patient group not responding to IVIG and aspirin, the risk of coronary artery compli cations is very high. For these problems, many studies have been conducted for the early identification of patients who do not respond to IVIG. Many reports have been made particularly in Japan, and they reported involved factors such as pediatric patients' age, dura tion between the onset of fever and the administration of IVIG, sodium level, proportion of neutrophil, Creactive protein (CRP), platelet count 6) , albumin 7) , total bilirubin, aspartate amino transferase (AST) 8) , and alanine aminotransferase (ALT) 9) , and developed riskscoring systems using several factors. Never theless, there are no agreed factors for predicting patients not responding to IVIG.
Thus, the present authors conducted this study in order to find clinical patterns and laboratory findings important for predicting patients not responding to IVIG.
Materials and methods

Patients
The subjects of this study were 309 patients diagnosed with KD and treated at the Kyungpook National University Hospital and the Inje University Busan Paik Hospital during the period from January 2005 to June 2011. KD was diagnosed according to the criteria published by American Heart Association in 2004 2) . For all the patients, we collected samples on the day of admission or before immunoglobulin treatment, and measured hemoglobin (Hb), white blood cell, proportion of neutrophil, platelet count, erythrocyte sedimentation rate, CRP, AST, ALT, sodium, potassium, total protein, albumin, total bilirubin, total cholesterol, triglyceride, high density lipoprotein (HDL), and Nterminal fragment of Btype natriuretic peptide (NTproBNP).
All of the patients were administered with IVIG (2 g/kg) and highdose aspirin (80-100 mg/kg/day). Those who showed improvement in fever and other symptoms after the admini stration of IVIG were classified as IVIGresponders, and those whose fever continued for over 36 hours or who had re cru descent fever (temperature≥38.0℃ axillary or rectally) were classified as IVIGnonresponders. In addition, echo cardio graphy was performed to measure coronary artery size at diag nosis. Coronary artery lesion was defined as follows; 1) coronary artery diameter had a Zscore≥2.5, 2) size of coronary artery had 1.5 times larger than other lesions 2) .
Risk-scoring systems
The parameters of Kobayashi score 6) are as follows: 1) sodium ≤133 mmol/L, 2 points; 2) days of illness at initial treatment ≤4 days, 2 points; 3) AST ≥100 IU/L, 2 points; 4) % of neutrophil≥80, 2 points; 5) CRP≥10 mg/dL, 1 point; 6) age≤12 months, 1 point; and 7) platelet count≤300×10 point; 2) CRP≥7 mg/dL, 1 point; and 3) total bilirubin≥0.9 mg/ dL, 1 point. By applying each scoring system to our data, we divided the subjects into lowrisk and highrisk groups and obtained sen sitivity and specificity.
Statistical analysis
The groups were compared through MannWhitney Utest and Student's ttest. And comparison according to age, weight and gender and the comparison of the frequency of coronary artery lesion were made through chisquare test using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). We determined signifi cant parameters by univariate analyses, and then the cutoff values of these factors were obtained using receiver operating characteristic (ROC) curve. With these factors in addition to age (not older than 12 months), the duration of fever at the beginning of treatment (not longer than 4 days) and gender (male), which are factors suggested as the predictors of IVIG resistant KD suggested in the previous reports 69) , we performed multivariable logistic regression analysis. In all analyses, the statistical significance of difference was accepted if P<0.05.
Ethics statement
The study protocol was reviewed and approved by the Insti tutional Review Board (IRB) of the Inje University Busan Paik Hospital (IRB No. 12053).
Results
Comparison of clinical findings between groups
Among the 309 patients, 30 (9.7%) did not respond to IVIG. Between the IVIGresponders and IVIGnonresponders, no difference was observed in age, gender, and the duration of fever on diagnosis (P=0.987, P=0.195, and P=0.737). The clinical pattern of KD was not different between the two groups, but the frequency of sterile pyuria was higher in the IVIGnonr esponders (19/30, 63.3%) than in the IVIGresponders (67/279, 24.0%), and hospitalization time was also around two times longer in the IVIGnonresponders (P<0.001). The frequency of coronary artery lesion was 43.3% (13/30) in the IVIGnonre sponders, more frequent than 6.8% (19/279) in the IVIGrespon ders (P<0.001) ( Table 1) .
Of the 30 IVIGnonresponders, 22 were retreated with IVIG (2 g/kg). Six did not respond to IVIGretreatment were given pulse methylprednisolone (30 mg/kg dose for 3 days), and 2 who did not respond to IVIG and steroid was treated with infli ximab (5 Korean J Pediatr 2013;56(2):75-79 mg/kg).
Comparison of biological markers and risk-scoring systems between groups
AST, ALT, total bilirubin, % neutrophils, and NTproBNP were significantly higher in the IVIGnonresponders than in the IVIGresponders, and sodium level and HDL level were lower in the IVIGnonresponders than in the IVIGresponders. Previously reported risk factors such as CRP, platelet count, and albumin were not significantly different in this study (Table 2 ). When data on our patients was applied to Kobayashi score 6) , Sano score 8) , Egami score 9) , and which are riskscoring systems for predicting IVIGresistant KD, were significantly higher in the IVIGnonresponder group. The sensitivity and specificity of the Kobayashi model was 60% and 74%, respec tively, and those of the Egami model were 57% and 77%, re spectively. The Sano model showed sensitivity of 60% and specificity of 90% (Table 3) .
Cutoff values of biomarkers by ROC curve
For each biomarker, the cutoff value was decided by the ROC curve. When the cutoff value of % neutrophils for identifying IVIGnonresponders was set to 76%, the area under the ROC curve was 0.689 (95% confidence interval [CI], 0.580 to 0.798), sensitivity was 63%, and specificity was 74%. When the cutoff value of AST was 56 IU/dL, the area under the ROC curve was 0.683 (95% CI, 0.564 to 0.801), sensitivity was 60%, and specificity was 71%. For ALT, at cutoff value of 84 IU/dL, the area under the ROC curve was 0.751 (95% CI, 0.654 to 0.847), sensitivity was 73%, and specificity was 75%. At cutoff value 0.9 mg/dL of total bilirubin, the area under the ROC curve was 0.739 (95% CI, 0.627 to 0.852), sensitivity was 70%, and speci ficity was 86%. At cutoff value 136 mmol/L of sodium level, the area under the ROC curve was 0.706 (95% CI, 0.626 to 0.786), sensitivity was 70%, and specificity was 59%.
Independent predictors of IVIG-nonresponders
According to the results of multivariable logistic regression analysis, the independent risk factors of IVIGnonresponders were ALT≥84 IU/dL and total bilirubin≥0.9 mg/dL. The odds ratio was 3.8 for ALT, and 5.3 for total bilirubin. Having both of the two predictors (ALT≥84 IU/dL, total bilirubin≥0.9 mg/ dL) in laboratory findings showed higher sensitivity and speci ficity (63% and 90%, respectively) than the existing models in predicting KD patients not responding to initial IVIG (Table 4) . (10) 18 (60) Values are presented as mean±standard deviation or number (%). *Scores calculated by Kobayashi predictive system 6) . † Scores by Egami system 9) . ‡ Scores by Sano system 8) .
Discussion
From the results of this study, we found two predictors (ALT≥ 84 IU/dL and total bilirubin≥0.9 mg/dL) for KD not responding to initial IVIG treatment. In addition, the frequency of coronary artery lesion was much higher in IVIGresistant KD, and pulse methylprednisolone and antitumor necrosis factor (TNF)α monoclonal antibody (infliximab) were found to be useful and effective as rescue therapy.
Research is being made actively for reducing the duration of fever and coronary artery lesions through early detection and treatment of patients not responding to IVIG, who occupy around 10% to 20% of KD. Still, no agreed risk factors have been found. Many of studies on such risk factors were conducted with Japanese patients, and Kobayashi et al. 6) , Sano et al. 8) ,
Egami et al. 9) , etc. proposed scoring system for predicting IVIG nonresponders using various parameters. When these risk scoring systems were applied to the subjects of our study, spe cificity was high (74% to 90%) but sensitivity was low (57% to 60%), so they had difficulty in screening out highrisk patients who need intensive treatment. After all, there is a problem in applying the riskscoring systems, which are effective to Japanese pediatric patients, to Korean pediatric patients due to difference in genetic factors between Japanese and Korean patients.
In other studies, Ashouri et al. 7) reported risk predictors such as high percent band count, low albumin and the presence of coronary artery lesions. Tremoulet et al. 10) mentioned high percent band count, long illness day, high gammaglutamyl transferase, and low ageadjusted Hb as the risk predictors of IVIGnonresponders. In Korea as well, Do et al. 11) reported that low albumin, low sodium, and high neutrophil proportion were significant in the IVIGresistant group. Changes in these biomarkers are the effects of diverse cytokines (inter leukin [IL]1β, TNFα, interferon (IFN)γ, IFNα, IL4, IL6, IL8, IL10, transforming growth factorβ, matrix metalloproteinase, vas cular endothelial growth factor (VEGF) increasing at the early stage 2, 5) . The elevation of VEGF induces the increase of vascular leakage, which in turn, decreases albumin. Furthermore, cytokine activated natural killer cells accumulate in vascular endo thelium and along liver sinusoids. As a result, inflamma tion of hepatic reticuloendothelial system and biliary tract occurs, that increases liver enzyme and total bilirubin 6, 12) . The accurate pathogenesis of hyponatremia in KD is unknown but is explained by the inappropriate secretion of antidiuretic hormone caused by cerebral vasculitis and the direct renal loss of sodium resulting from the renal involvement of KD 13) . As in the previous studies 69) , there were statistical differences in sodium level, liver enzymes (AST, ALT), total bilirubin, and neutrophil proportion in our study. The other parameters mentioned above were not significantly different. Moreover, high frequency of sterile pyuria, low HDL were observed in the IVIGnonresponder group. KD patients show abnormal urinary findings such as proteinuria, hematuria and sterile pyuria, and severe cases may have interstitial nephritis, acute renal failure, etc., rarely. Sterile pyuria is caused less by urethritis than by renal parenchymal injury and inflammation in KD, and it is also closely associated with cytokines 14) . KD causes also abnormalities in lipid metabolism due to the effects of cytokines such as TNFα, IL1 and IL6. With the decrease of HDL, triglyceride increases. TNFα and IL1 decreases HDL by damaging the activity of lipoprotein lipase, and increases triglyceride through decreasing circulating lipoprotein and increasing hepatic lipid synthesis 1517) . In our study, HDL was significantly different between the two groups, but because the value of lipid profile is affected by diet it may have a limitation as a predictive marker of IVIGresponders and IVIGnonresponders.
NTproBNP, a widely used biomarker of cardiovascular disease, is cardiac hormone secreted by the ventricles in response to sheer stress from the overload of body fluid and pressure. It is involved in diuresis, natriuresis, and arterial and venous dilatation and plays the role of regulating myocardial prolife ration and hypertrophic response 18, 19) . NTproBNP is a very important biomarker for the diagnosis, treatment and prognosis of heart failure in adults, and is a predictor of cardiac functions in patients after cardiac infarction 20, 21) . In pediatric patients as well, NTproBNP is a significant biomarker for heart failure, congenital heart disease with lefttoright shunt, cyanotic heart disease, right heart disease, secondary right heart disease induced by pulmonary hypertension and pulmonary regurgitation, and allograft disease after heart transplantation 2224) . Not as in other febrile illnesses, what is more, it increases at the acute stage of KD and decrease at the convalescent stage, so is useful for diagnosis 25) . Among cytokines, TNFα and IL1β accelerate the secretion of NTproBNP, and secondarily the secretion of NT proBNP is accelerated by sub clinical myocarditis and ischemia 26) . In this study, NTproBNP was statistically significantly higher in the IVIGnon responder group. Because its variation is large according to age, however, NTproBNP may be considered clinically but has a limitation in being used as a predictor 22) . With excluding parameters which have problems in being used as a predictor, we could obtain the predictors of KD non responsive to IVIG using risk factors confirmed from our data and several factors suggested in previous studies. ALT≥84 IU/ dL and total bilirubin≥0.9 mg/dL can be used as important independent risk factors for IVIGresistant KD. These results imply that severe inflammation spread to the hepatic reticulo endothelial system by the impact of several cytokines and natural killer cells in the IVIGnonresponder group.
Limitations of this study are that the number of IVIGnonre sponders was too small to represent the sample, and that the study was conducted retrospectively at two medical centers. In addition, echocardiography for diagnosing coronary artery lesions was performed by different examiners.
In conclusion, IVIG and high dose aspirin are established treatment methods of KD. There are still the controversial questions of what risk factors predict patients not responding to IVIG and what additional treatments should be applied to reduce coronary artery lesions. If a largescale study is conducted with the whole population of KD pediatric patients, we may find the risk factors of KD not responding to IVIG. Then, we may be able to suggest new treatment guidelines different from existing treatment methods and to prevent coronary artery complications caused by KD.
